subject area of
- Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here? Journal Articles
- Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer Journal Articles
- Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Journal Articles